ஒன்றுக்கு பெர்சன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஒன்றுக்கு பெர்சன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஒன்றுக்கு பெர்சன் Today - Breaking & Trending Today

Acarix AB: Positive, long term prognostic data from the Dan-NICAD I study published in European Heart Journal- Digital Health

Acarix AB: Positive, long term prognostic data from the Dan-NICAD I study published in European Heart Journal- Digital Health
Positive,
long term prognostic data from the Dan-NICAD I study published in European Heart Journal- Digital Health
Acarix AB (publ) today announced the publication of the Prognostic study, a study with long term follow up on patients from the Dan-NICAD 1 publication.
The long term Prognostic data from the Dan-NICAD 1 trial was first presented at the ESC Congress in September 2019 by Simon Winther, MD, PhD from Aarhus University Hospital, Denmark.
The Dan-NICAD 1 trial was initiated in September 2014 to assess non-invasive methods in patients referred to coronary CTA due to symptoms suggestive of obstructive CAD. Clinically relevant prognostic data were assessed with a median follow-up time of 3 years to evaluate the correlation between CAD-score and prognosis in patients treated by current standard of care. ....

Simon Winther , European Heart Digital Health , Aarhus University Hospital , European Heart Journal Digital Health , European Heart , Per Persson , European Heart Journal Digital , Nasdaq First North Premier Growth Market , Certified Adviser , சிமோன் விந்தர் , ஐரோப்பிய இதயம் டிஜிட்டல் ஆரோக்கியம் , ஆர்ஹஸ் பல்கலைக்கழகம் மருத்துவமனை , ஐரோப்பிய இதயம் இதழ் டிஜிட்டல் ஆரோக்கியம் , ஐரோப்பிய இதயம் , ஒன்றுக்கு பெர்சன் , ஐரோப்பிய இதயம் இதழ் டிஜிட்டல் , நாஸ்டாக் முதல் வடக்கு ப்ரிமியர் வளர்ச்சி சந்தை ,

LSI 2021 Emerging Medtech Summit to include 400+ Investors, Innovators and Strategics

LSI 2021 Emerging Medtech Summit to include 400+ Investors, Innovators and Strategics
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Kenneth Ross , Tarak Mehta , Dave Mildrew , Paul Laviolette , Kwame Ulmer , Nicholas Pachuda , Medtech Spacs , Manny Villafana , Bogart Parra Granados , Scott Pantel , Jaredt Williams , Josh Rabinowitz , Lisa Carmel , Daniel Teo , Matt Ahearn , Scott Huennekens , Siemens Healthineers , Tony Titus , Medtech Convergence Fund , Sv Health Investors , Boston Scientific , Alira Health , Sixty Health , Evonik Corporation , Ritz Carlton ,

MTV: Suvi Teräsniska uskoo uudelleensyntymään - meedio kertoi henkioppaasta

MTV: Suvi Teräsniska uskoo uudelleensyntymään - meedio kertoi henkioppaasta
iltalehti.fi - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iltalehti.fi Daily Mail and Mail on Sunday newspapers.

Berry Hintikka , Summer Steel Neck , Singer Summer Steel Neck , Steel Neck , Presenter Berry Hintikka , The Program , Per Persson , Swedish Lapland , From Lapland , Gold Mine , தி ப்ரோக்ர்யாம் , ஒன்றுக்கு பெர்சன் , ஸ்விட்ச் மடியில் , பழையது என்னுடையது ,

Acarix AB: A strong ending of an eventful year

Acarix AB: A strong ending of an eventful year
A strong ending of an eventful year
The fourth quarter contributed strongly to our overall performance in 2020, with the market approval for CADScor from the US Food and Drug Administration (FDA) as the outstanding achievement.
Extract from CEO Per Persson s message to the End Year Report.
Fourth quarter 2020 compared with same period 2019
During the fourth quarter, 22 CADScorSystem (10, of which 4 to clinical trials) and 1,420 (1,500, of which 840 to clinical trials) disposable patches were sold to end-users and distributors.
Revenue amounted to SEK 966 thousand (774), with gross profit of SEK 713 thousand (607) and a gross margin of 74 percent (78). ....

Christian Lindholm , Drug Administration , Year End Report , End Year , Certified Adviser , Coronary Artery , Per Persson , Nasdaq First North Premier Growth Market , கிறிஸ்துவர் லிண்ட்ஹோம் , ஆண்டு முடிவு அறிக்கை , முடிவு ஆண்டு , கரோனரி தமனி , ஒன்றுக்கு பெர்சன் , நாஸ்டாக் முதல் வடக்கு ப்ரிமியர் வளர்ச்சி சந்தை ,

Investegate |Acarix AB Announcements | Acarix AB: Positive preliminary data from Acarix's exploratory heart failure study SEISMO

Positive preliminary data from Acarix’s exploratory heart failure study SEISMO
Acarix AB (publ) today announced positive preliminary data from the exploratory SEISMO study, using its modified CADScor
®System on a potential heart failure application.
The SEISMO trial was initiated in June 2018 to evaluate the possibility of developing an algorithm that can differentiate patients referred with suspicion of heart failure. The study, with in total 199 patients at two sites in Denmark, included the last patient in 2020.
Completing the inclusion to the exploratory heart failure study was a great milestone for all involved. The new data looks promising for early heart failure rule out and will be important for all affected patients today waiting all too long for a final diagnosis. The data could warrant a follow-up study to consolidate findings and bring more data for algorithm development,” said Professor Peter Søgaard, MD and primary investigator. ....

Acarix Cadscor , Drug Administration , Per Persson , Real Life Data , Nasdaq First North Premier Growth Market , Certified Adviser , Investegate Announcements , Investegate Company Announcements , Acarix Ab , Globe Newswire , Globenewswire And , ஒன்றுக்கு பெர்சன் , ரியல் வாழ்க்கை தகவல்கள் , நாஸ்டாக் முதல் வடக்கு ப்ரிமியர் வளர்ச்சி சந்தை ,